iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 9 PAGES: 46

More Info
									              iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME232FSA                                                                                            Publication Date: JUN 2013

          98 Spit Brook Road, Suite 100                      Phone              +1 603 8825200                  Revenue          28.3 (million USD)
          Nashua, NH                                         Fax                +1 603 8803843                  Net Profit       -9.37 (million USD)
          03062                                              Website            www.icadmed.com                 Employees        101
          United States                                      Exchange           ICAD [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       iCAD, Inc. (iCAD) is a medical device company, which develops and markets computer aided detection (CAD) solutions and
       workflow solutions. The company’s products include Mammography CAD, MRI image analysis solutions and CT Colon CAD. The
       Mammography CAD includes SecondLook Premier, SecondLook Digital, SecondLook Multi-Vendor solution, breast density
       assessment option, TotalLook MammoAdvantage, analog CAD and connectivity solutions. The MRI image analysis solutions
       comprise SpectraLook for breast, VividLook for prostate, Omnilook for other organs, PrecisionPoint for breast cancer. iCAD
       primarily operates in the US and it also exports products to various countries in Europe and Asia.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      iCAD, Inc., SWOT Analysis
         Kenneth M. Ferry                    Chief Executive Officer                  Strengths                              Weaknesses
         Dr. Lawrence Howard                 Chairman
                                                                                      Strong R&D and Intellectual            Dependence on a Limited
         Steven Rappaport                    Director                                 Property                               Number of Suppliers
         Rachel Brem, MD                     Director
                                                                                      Improved Liquidity                     Operational Losses
         Anthony Ecock                       Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Mammography and CT Imaging Diagnostic Imaging Tests
         iCAD, Inc.                                                                   Market                     Reimbursement Reductions
        Share Price (USD) as on 04-Jun-                                  6.01         Key Business Initiatives               Rapid Technological Change
        2013
        EPS (USD)                                                       -0.87
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                           65        GlobalData

        Enterprise Value (million USD)                                     67
        Shares Outstanding (million)                                       11
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Apr 29, 2013         iCAD Reports Revenue Of $7.9m In Q1 2013
                                                                                      Feb 19, 2013         iCAD Reports Revenue Of $28.3m In 2012
                                                                                      Jan 07, 2013         iCAD Receives FDA Approval For Digital CAD
                                                                                                           With Philips Digital Mammography System
                                                                                      Nov 25, 2012         iCAD To Introduce VersaVue Enterprise 3.2.1
                                                                                                           At RSNA 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review                                                                 Reference Code: GDME232FSA
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       iCAD, Inc. - Key Facts ........................................................................................................................................................................ 5
       iCAD, Inc. - Key Employees ............................................................................................................................................................... 6
       iCAD, Inc. - Key Employee Biographies ............................................................................................................................................. 7
       iCAD, Inc. - Major Products and Services .......................................................................................................................................... 8
       iCAD, Inc. - Medical Equipment Pipeline Products Data .................................................................................................................... 9
          iCAD, Inc. Pipeline Products by Equipment Type ........................................................................................................................... 9
          iCAD, Inc. Pipeline Products by Development Stage.................................................................................................................... 11
       iCAD, Inc. - History ........................................................................................................................................................................... 13
       iCAD, Inc. - Company Statement ..................................................................................................................................................... 15
       iCAD, Inc. - Locations And Subsidiaries ........................................................................................................................................... 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
       Section 2 – Company Analysis ......................................................................................................................................................... 18
       iCAD, Inc. - Business Description ..................................................................................................................................................... 18
       iCAD, Inc. - Corporate Strategy ........................................................................................................................................................ 19
       iCAD, Inc. - SWOT Analysis ............................................................................................................................................................. 20
          SWOT Analysis - Overview........................................................................................................................................................... 20
          iCAD, Inc. - Strengths ................................................................................................................................................................... 20
             Strength - Strong R&D and Intellectual Property ....................................................................................................................... 20
             Strength - Improved Liquidity .................................................................................................................................................... 20
             Strength - Range of Offerings ................................................................................................................................................... 20
          iCAD, Inc. - Weaknesses .............................................................................................................................................................. 20
             Weakness - Dependence on a Limited Number of Suppliers .................................................................................................... 20
             Weakness - Operational Losses ............................................................................................................................................... 21
          iCAD, Inc. - Opportunities ............................................................................................................................................................. 21
             Opportunity - Mammography and CT Imaging Market .............................................................................................................. 21
             Opportunity - Key Business Initiatives ....................................................................................................................................... 21
             Opportunity - Growing Aged Population .................................................................................................................................... 21
          iCAD, Inc. - Threats ...................................................................................................................................................................... 21
             Threat - Diagnostic Imaging Tests Reimbursement Reductions ............................................................................................... 21
             Threat - Rapid Technological Change ....................................................................................................................................... 22
             Threat - Highly Competitive Environment .................................................................................................................................. 22
       iCAD, Inc. - Key Competitors............................................................................................................................................................ 23
       Section 3 – Company Financial Ratios ............................................................................................................................................. 24
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 24
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 24
       Performance Chart ........................................................................................................................................................................... 26
       Financial Performance...................................................................................................................................................................... 26
       Financial Ratios - Interim Ratios....................................................................................................................................................... 27
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 28
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 29



iCAD, Inc. (ICAD) - Financial and Strategic SWOT Analysis Review                                                                                                  Reference Code: GDME232FSA
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          iCAD, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 ............................................................................................. 29
          iCAD, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013 ............................................................................................. 30
          iCAD, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................................ 31
          iCAD, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ........................................................................... 32
       iCAD, Inc., Recent Deals Summary ................................................................................................................................................. 33
       Section 5 – Company’s Recent Developments ................................................................................................................................ 34
          iCAD, Inc., Recent Developments .......................................................................................................
								
To top